Chimeric antigen receptor-engineered natural killer cells: a promising cancer immunotherapy.

Document Type

Journal Article

Publication Date

4-12-2021

Journal

Expert Review of Clinical Immunology

Inclusive Pages

1-17

DOI

10.1080/1744666X.2021.1911648

Comments

Online ahead of print

Peer Reviewed

1

Find in your library

Share

COinS